nodes	percent_of_prediction	percent_of_DWPC	metapath
Zoledronate—CA2—glaucoma	0.302	1	CbGaD
Zoledronate—CA14—Brinzolamide—glaucoma	0.0505	0.0969	CbGbCtD
Zoledronate—CA14—Diclofenamide—glaucoma	0.0505	0.0969	CbGbCtD
Zoledronate—CA14—Dorzolamide—glaucoma	0.0488	0.0936	CbGbCtD
Zoledronate—CA14—Methazolamide—glaucoma	0.0435	0.0834	CbGbCtD
Zoledronate—CA12—Diclofenamide—glaucoma	0.0359	0.0689	CbGbCtD
Zoledronate—CA12—Brinzolamide—glaucoma	0.0359	0.0689	CbGbCtD
Zoledronate—CA14—Acetazolamide—glaucoma	0.0348	0.0667	CbGbCtD
Zoledronate—CA12—Dorzolamide—glaucoma	0.0347	0.0665	CbGbCtD
Zoledronate—CA12—Methazolamide—glaucoma	0.0309	0.0593	CbGbCtD
Zoledronate—CA2—Brinzolamide—glaucoma	0.029	0.0557	CbGbCtD
Zoledronate—CA2—Diclofenamide—glaucoma	0.029	0.0557	CbGbCtD
Zoledronate—CA2—Dorzolamide—glaucoma	0.028	0.0538	CbGbCtD
Zoledronate—CA2—Methazolamide—glaucoma	0.025	0.0479	CbGbCtD
Zoledronate—CA12—Acetazolamide—glaucoma	0.0247	0.0474	CbGbCtD
Zoledronate—CA2—Acetazolamide—glaucoma	0.02	0.0383	CbGbCtD
Zoledronate—CA14—Reversible hydration of carbon dioxide—CA5A—glaucoma	0.00934	0.169	CbGpPWpGaD
Zoledronate—CA12—Reversible hydration of carbon dioxide—CA5A—glaucoma	0.00787	0.142	CbGpPWpGaD
Zoledronate—CA2—Reversible hydration of carbon dioxide—CA5A—glaucoma	0.00602	0.109	CbGpPWpGaD
Zoledronate—CA14—Reversible hydration of carbon dioxide—CA1—glaucoma	0.00456	0.0825	CbGpPWpGaD
Zoledronate—CA14—Reversible hydration of carbon dioxide—CA2—glaucoma	0.00417	0.0754	CbGpPWpGaD
Zoledronate—CA12—Reversible hydration of carbon dioxide—CA1—glaucoma	0.00384	0.0695	CbGpPWpGaD
Zoledronate—CA2—Erythrocytes take up carbon dioxide and release oxygen—CA1—glaucoma	0.0037	0.0669	CbGpPWpGaD
Zoledronate—CA12—Reversible hydration of carbon dioxide—CA2—glaucoma	0.00352	0.0636	CbGpPWpGaD
Zoledronate—CA2—Reversible hydration of carbon dioxide—CA1—glaucoma	0.00294	0.0532	CbGpPWpGaD
Zoledronate—ABCC1—ABC-family proteins mediated transport—PEX19—glaucoma	0.00103	0.0186	CbGpPWpGaD
Zoledronate—Risedronate—PTGS2—glaucoma	0.000439	0.529	CrCbGaD
Zoledronate—GGPS1—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000413	0.00746	CbGpPWpGaD
Zoledronate—Clodronate—PTGS2—glaucoma	0.000391	0.471	CrCbGaD
Zoledronate—GGPS1—Metabolism—NARFL—glaucoma	0.000389	0.00703	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—CA5A—glaucoma	0.000389	0.00703	CbGpPWpGaD
Zoledronate—CA14—Metabolism—NARFL—glaucoma	0.00019	0.00343	CbGpPWpGaD
Zoledronate—CA14—Metabolism—CA5A—glaucoma	0.00019	0.00343	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—CA1—glaucoma	0.00019	0.00343	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—CTSA—glaucoma	0.000184	0.00332	CbGpPWpGaD
Zoledronate—ABCC1—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000181	0.00327	CbGpPWpGaD
Zoledronate—ABCC1—S1P1 pathway—PTGS2—glaucoma	0.000177	0.0032	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000176	0.00319	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—CA2—glaucoma	0.000174	0.00314	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	0.00017	0.00307	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	0.00017	0.00307	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—NARFL—glaucoma	0.000166	0.003	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—CA5A—glaucoma	0.000166	0.003	CbGpPWpGaD
Zoledronate—CA12—Metabolism—CA5A—glaucoma	0.00016	0.00289	CbGpPWpGaD
Zoledronate—CA12—Metabolism—NARFL—glaucoma	0.00016	0.00289	CbGpPWpGaD
Zoledronate—ABCC1—S1P1 pathway—VEGFA—glaucoma	0.000139	0.00252	CbGpPWpGaD
Zoledronate—CA2—Metabolism—NARFL—glaucoma	0.000122	0.00221	CbGpPWpGaD
Zoledronate—CA2—Metabolism—CA5A—glaucoma	0.000122	0.00221	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—TXN—glaucoma	0.000122	0.00221	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism of lipids and lipoproteins—APOE—glaucoma	0.000112	0.00202	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	0.000111	0.002	CbGpPWpGaD
Zoledronate—GGPS1—retina—glaucoma	0.000109	0.221	CbGeAlD
Zoledronate—ABCC1—Transmembrane transport of small molecules—PEX19—glaucoma	0.000107	0.00194	CbGpPWpGaD
Zoledronate—GGPS1—connective tissue—glaucoma	0.000106	0.215	CbGeAlD
Zoledronate—GGPS1—Metabolism—GSTT1—glaucoma	9.48e-05	0.00172	CbGpPWpGaD
Zoledronate—CA14—Metabolism—CA1—glaucoma	9.27e-05	0.00168	CbGpPWpGaD
Zoledronate—CA14—Metabolism—CTSA—glaucoma	8.98e-05	0.00162	CbGpPWpGaD
Zoledronate—CA14—Metabolism—CA2—glaucoma	8.48e-05	0.00153	CbGpPWpGaD
Zoledronate—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—glaucoma	8.2e-05	0.00148	CbGpPWpGaD
Zoledronate—ABCC1—Arachidonic acid metabolism—PTGS2—glaucoma	8.15e-05	0.00147	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—CA1—glaucoma	8.1e-05	0.00147	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—CTSA—glaucoma	7.85e-05	0.00142	CbGpPWpGaD
Zoledronate—CA12—Metabolism—CA1—glaucoma	7.81e-05	0.00141	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	7.65e-05	0.00138	CbGpPWpGaD
Zoledronate—CA12—Metabolism—CTSA—glaucoma	7.57e-05	0.00137	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—CYP1B1—glaucoma	7.56e-05	0.00137	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—ABCA1—glaucoma	7.56e-05	0.00137	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—CA2—glaucoma	7.41e-05	0.00134	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—SLC4A4—glaucoma	7.26e-05	0.00131	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	7.24e-05	0.00131	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	7.24e-05	0.00131	CbGpPWpGaD
Zoledronate—CA12—Metabolism—CA2—glaucoma	7.15e-05	0.00129	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—CTSA—glaucoma	6.29e-05	0.00114	CbGpPWpGaD
Zoledronate—Arrhythmia—Betaxolol—glaucoma	6.22e-05	0.000518	CcSEcCtD
Zoledronate—Feeling abnormal—Dorzolamide—glaucoma	6.2e-05	0.000516	CcSEcCtD
Zoledronate—Decreased appetite—Pilocarpine—glaucoma	6.18e-05	0.000515	CcSEcCtD
Zoledronate—Feeling abnormal—Travoprost—glaucoma	6.18e-05	0.000514	CcSEcCtD
Zoledronate—Conjunctivitis—Timolol—glaucoma	6.16e-05	0.000513	CcSEcCtD
Zoledronate—Gastrointestinal pain—Dorzolamide—glaucoma	6.16e-05	0.000512	CcSEcCtD
Zoledronate—Alopecia—Betaxolol—glaucoma	6.15e-05	0.000512	CcSEcCtD
Zoledronate—Palpitations—Clonidine—glaucoma	6.15e-05	0.000512	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Pilocarpine—glaucoma	6.14e-05	0.000511	CcSEcCtD
Zoledronate—Gastrointestinal pain—Travoprost—glaucoma	6.13e-05	0.00051	CcSEcCtD
Zoledronate—Loss of consciousness—Clonidine—glaucoma	6.12e-05	0.000509	CcSEcCtD
Zoledronate—Feeling abnormal—Brinzolamide—glaucoma	6.1e-05	0.000508	CcSEcCtD
Zoledronate—Mental disorder—Betaxolol—glaucoma	6.1e-05	0.000508	CcSEcCtD
Zoledronate—Constipation—Pilocarpine—glaucoma	6.08e-05	0.000506	CcSEcCtD
Zoledronate—Pain—Pilocarpine—glaucoma	6.08e-05	0.000506	CcSEcCtD
Zoledronate—Cough—Clonidine—glaucoma	6.07e-05	0.000506	CcSEcCtD
Zoledronate—Dizziness—Apraclonidine—glaucoma	6.07e-05	0.000505	CcSEcCtD
Zoledronate—Malnutrition—Betaxolol—glaucoma	6.06e-05	0.000504	CcSEcCtD
Zoledronate—Erythema—Betaxolol—glaucoma	6.06e-05	0.000504	CcSEcCtD
Zoledronate—GGPS1—Metabolism—GSTM1—glaucoma	6.04e-05	0.00109	CbGpPWpGaD
Zoledronate—Urticaria—Dorzolamide—glaucoma	5.98e-05	0.000498	CcSEcCtD
Zoledronate—CA2—Metabolism—CA1—glaucoma	5.97e-05	0.00108	CbGpPWpGaD
Zoledronate—CA14—Metabolism—TXN—glaucoma	5.97e-05	0.00108	CbGpPWpGaD
Zoledronate—Abdominal pain—Dorzolamide—glaucoma	5.95e-05	0.000495	CcSEcCtD
Zoledronate—Body temperature increased—Dorzolamide—glaucoma	5.95e-05	0.000495	CcSEcCtD
Zoledronate—Dysgeusia—Betaxolol—glaucoma	5.93e-05	0.000494	CcSEcCtD
Zoledronate—Chest pain—Clonidine—glaucoma	5.93e-05	0.000493	CcSEcCtD
Zoledronate—Arthralgia—Clonidine—glaucoma	5.93e-05	0.000493	CcSEcCtD
Zoledronate—Abdominal pain—Travoprost—glaucoma	5.93e-05	0.000493	CcSEcCtD
Zoledronate—ABCC1—Metabolism—NARFL—glaucoma	5.92e-05	0.00107	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CA5A—glaucoma	5.92e-05	0.00107	CbGpPWpGaD
Zoledronate—Agranulocytosis—Timolol—glaucoma	5.91e-05	0.000492	CcSEcCtD
Zoledronate—Anxiety—Clonidine—glaucoma	5.91e-05	0.000492	CcSEcCtD
Zoledronate—Asthenia—Acetazolamide—glaucoma	5.89e-05	0.000491	CcSEcCtD
Zoledronate—Dizziness—Bimatoprost—glaucoma	5.89e-05	0.00049	CcSEcCtD
Zoledronate—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	5.88e-05	0.00049	CcSEcCtD
Zoledronate—Urticaria—Brinzolamide—glaucoma	5.88e-05	0.000489	CcSEcCtD
Zoledronate—Feeling abnormal—Pilocarpine—glaucoma	5.86e-05	0.000488	CcSEcCtD
Zoledronate—Discomfort—Clonidine—glaucoma	5.85e-05	0.000487	CcSEcCtD
Zoledronate—Vomiting—Apraclonidine—glaucoma	5.84e-05	0.000486	CcSEcCtD
Zoledronate—Muscle spasms—Betaxolol—glaucoma	5.83e-05	0.000485	CcSEcCtD
Zoledronate—Gastrointestinal pain—Pilocarpine—glaucoma	5.82e-05	0.000484	CcSEcCtD
Zoledronate—Hypersensitivity—Brimonidine—glaucoma	5.81e-05	0.000483	CcSEcCtD
Zoledronate—Dry mouth—Clonidine—glaucoma	5.8e-05	0.000482	CcSEcCtD
Zoledronate—Bradycardia—Timolol—glaucoma	5.79e-05	0.000482	CcSEcCtD
Zoledronate—CA2—Metabolism—CTSA—glaucoma	5.78e-05	0.00105	CbGpPWpGaD
Zoledronate—Dermatitis—Apraclonidine—glaucoma	5.78e-05	0.000481	CcSEcCtD
Zoledronate—Headache—Apraclonidine—glaucoma	5.75e-05	0.000479	CcSEcCtD
Zoledronate—Confusional state—Clonidine—glaucoma	5.73e-05	0.000477	CcSEcCtD
Zoledronate—Vision blurred—Betaxolol—glaucoma	5.71e-05	0.000475	CcSEcCtD
Zoledronate—Oedema—Clonidine—glaucoma	5.68e-05	0.000473	CcSEcCtD
Zoledronate—Tremor—Betaxolol—glaucoma	5.68e-05	0.000473	CcSEcCtD
Zoledronate—Asthenia—Brimonidine—glaucoma	5.66e-05	0.000471	CcSEcCtD
Zoledronate—Infection—Clonidine—glaucoma	5.64e-05	0.00047	CcSEcCtD
Zoledronate—Abdominal pain—Pilocarpine—glaucoma	5.62e-05	0.000468	CcSEcCtD
Zoledronate—Body temperature increased—Pilocarpine—glaucoma	5.62e-05	0.000468	CcSEcCtD
Zoledronate—Ill-defined disorder—Betaxolol—glaucoma	5.62e-05	0.000468	CcSEcCtD
Zoledronate—Diarrhoea—Acetazolamide—glaucoma	5.62e-05	0.000468	CcSEcCtD
Zoledronate—Rash—Bimatoprost—glaucoma	5.61e-05	0.000467	CcSEcCtD
Zoledronate—Dermatitis—Bimatoprost—glaucoma	5.61e-05	0.000467	CcSEcCtD
Zoledronate—Oedema peripheral—Timolol—glaucoma	5.6e-05	0.000466	CcSEcCtD
Zoledronate—Anaemia—Betaxolol—glaucoma	5.6e-05	0.000466	CcSEcCtD
Zoledronate—Shock—Clonidine—glaucoma	5.59e-05	0.000465	CcSEcCtD
Zoledronate—Connective tissue disorder—Timolol—glaucoma	5.59e-05	0.000465	CcSEcCtD
Zoledronate—Pruritus—Brimonidine—glaucoma	5.58e-05	0.000464	CcSEcCtD
Zoledronate—Headache—Bimatoprost—glaucoma	5.58e-05	0.000464	CcSEcCtD
Zoledronate—Nervous system disorder—Clonidine—glaucoma	5.57e-05	0.000464	CcSEcCtD
Zoledronate—Thrombocytopenia—Clonidine—glaucoma	5.56e-05	0.000463	CcSEcCtD
Zoledronate—Hypersensitivity—Dorzolamide—glaucoma	5.55e-05	0.000462	CcSEcCtD
Zoledronate—Tachycardia—Clonidine—glaucoma	5.54e-05	0.000462	CcSEcCtD
Zoledronate—Hypersensitivity—Travoprost—glaucoma	5.52e-05	0.00046	CcSEcCtD
Zoledronate—Skin disorder—Clonidine—glaucoma	5.52e-05	0.000459	CcSEcCtD
Zoledronate—Hyperhidrosis—Clonidine—glaucoma	5.49e-05	0.000457	CcSEcCtD
Zoledronate—Malaise—Betaxolol—glaucoma	5.46e-05	0.000455	CcSEcCtD
Zoledronate—Nausea—Apraclonidine—glaucoma	5.45e-05	0.000454	CcSEcCtD
Zoledronate—Hypersensitivity—Brinzolamide—glaucoma	5.45e-05	0.000454	CcSEcCtD
Zoledronate—Vertigo—Betaxolol—glaucoma	5.44e-05	0.000453	CcSEcCtD
Zoledronate—Syncope—Betaxolol—glaucoma	5.43e-05	0.000452	CcSEcCtD
Zoledronate—Dizziness—Acetazolamide—glaucoma	5.43e-05	0.000452	CcSEcCtD
Zoledronate—Anorexia—Clonidine—glaucoma	5.41e-05	0.000451	CcSEcCtD
Zoledronate—Asthenia—Dorzolamide—glaucoma	5.4e-05	0.00045	CcSEcCtD
Zoledronate—Asthenia—Travoprost—glaucoma	5.38e-05	0.000448	CcSEcCtD
Zoledronate—ABCC1—Disease—LRP12—glaucoma	5.36e-05	0.000969	CbGpPWpGaD
Zoledronate—Palpitations—Betaxolol—glaucoma	5.35e-05	0.000446	CcSEcCtD
Zoledronate—GGPS1—Metabolism—MTHFR—glaucoma	5.34e-05	0.000965	CbGpPWpGaD
Zoledronate—Pruritus—Dorzolamide—glaucoma	5.33e-05	0.000443	CcSEcCtD
Zoledronate—Loss of consciousness—Betaxolol—glaucoma	5.33e-05	0.000443	CcSEcCtD
Zoledronate—Eye disorder—Timolol—glaucoma	5.31e-05	0.000442	CcSEcCtD
Zoledronate—Asthenia—Brinzolamide—glaucoma	5.31e-05	0.000442	CcSEcCtD
Zoledronate—Hypotension—Clonidine—glaucoma	5.31e-05	0.000442	CcSEcCtD
Zoledronate—Pruritus—Travoprost—glaucoma	5.3e-05	0.000441	CcSEcCtD
Zoledronate—Cough—Betaxolol—glaucoma	5.29e-05	0.00044	CcSEcCtD
Zoledronate—Nausea—Bimatoprost—glaucoma	5.29e-05	0.00044	CcSEcCtD
Zoledronate—Cardiac disorder—Timolol—glaucoma	5.28e-05	0.000439	CcSEcCtD
Zoledronate—Hypersensitivity—Pilocarpine—glaucoma	5.24e-05	0.000436	CcSEcCtD
Zoledronate—Pruritus—Brinzolamide—glaucoma	5.24e-05	0.000436	CcSEcCtD
Zoledronate—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—glaucoma	5.23e-05	0.000946	CbGpPWpGaD
Zoledronate—Vomiting—Acetazolamide—glaucoma	5.22e-05	0.000435	CcSEcCtD
Zoledronate—FDPS—Metabolism—TXN—glaucoma	5.22e-05	0.000944	CbGpPWpGaD
Zoledronate—Dizziness—Brimonidine—glaucoma	5.21e-05	0.000434	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Clonidine—glaucoma	5.18e-05	0.000431	CcSEcCtD
Zoledronate—Angiopathy—Timolol—glaucoma	5.16e-05	0.000429	CcSEcCtD
Zoledronate—Arthralgia—Betaxolol—glaucoma	5.16e-05	0.000429	CcSEcCtD
Zoledronate—Myalgia—Betaxolol—glaucoma	5.16e-05	0.000429	CcSEcCtD
Zoledronate—Chest pain—Betaxolol—glaucoma	5.16e-05	0.000429	CcSEcCtD
Zoledronate—Diarrhoea—Dorzolamide—glaucoma	5.15e-05	0.000429	CcSEcCtD
Zoledronate—Headache—Acetazolamide—glaucoma	5.15e-05	0.000428	CcSEcCtD
Zoledronate—Anxiety—Betaxolol—glaucoma	5.14e-05	0.000428	CcSEcCtD
Zoledronate—CA12—eye—glaucoma	5.14e-05	0.104	CbGeAlD
Zoledronate—Insomnia—Clonidine—glaucoma	5.14e-05	0.000428	CcSEcCtD
Zoledronate—Immune system disorder—Timolol—glaucoma	5.14e-05	0.000428	CcSEcCtD
Zoledronate—Diarrhoea—Travoprost—glaucoma	5.13e-05	0.000427	CcSEcCtD
Zoledronate—Mediastinal disorder—Timolol—glaucoma	5.12e-05	0.000427	CcSEcCtD
Zoledronate—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	5.12e-05	0.000426	CcSEcCtD
Zoledronate—Asthenia—Pilocarpine—glaucoma	5.1e-05	0.000425	CcSEcCtD
Zoledronate—Paraesthesia—Clonidine—glaucoma	5.1e-05	0.000425	CcSEcCtD
Zoledronate—Discomfort—Betaxolol—glaucoma	5.1e-05	0.000424	CcSEcCtD
Zoledronate—FDPS—eye—glaucoma	5.08e-05	0.103	CbGeAlD
Zoledronate—Arrhythmia—Timolol—glaucoma	5.08e-05	0.000423	CcSEcCtD
Zoledronate—Dyspnoea—Clonidine—glaucoma	5.06e-05	0.000422	CcSEcCtD
Zoledronate—Diarrhoea—Brinzolamide—glaucoma	5.06e-05	0.000422	CcSEcCtD
Zoledronate—Somnolence—Clonidine—glaucoma	5.05e-05	0.00042	CcSEcCtD
Zoledronate—Dry mouth—Betaxolol—glaucoma	5.05e-05	0.00042	CcSEcCtD
Zoledronate—CA12—Metabolism—TXN—glaucoma	5.03e-05	0.00091	CbGpPWpGaD
Zoledronate—Pruritus—Pilocarpine—glaucoma	5.03e-05	0.000419	CcSEcCtD
Zoledronate—Alopecia—Timolol—glaucoma	5.03e-05	0.000418	CcSEcCtD
Zoledronate—Confusional state—Betaxolol—glaucoma	4.99e-05	0.000415	CcSEcCtD
Zoledronate—Mental disorder—Timolol—glaucoma	4.98e-05	0.000415	CcSEcCtD
Zoledronate—Dizziness—Dorzolamide—glaucoma	4.98e-05	0.000414	CcSEcCtD
Zoledronate—GGPS1—Metabolism—APOE—glaucoma	4.97e-05	0.000899	CbGpPWpGaD
Zoledronate—Rash—Brimonidine—glaucoma	4.97e-05	0.000414	CcSEcCtD
Zoledronate—Dermatitis—Brimonidine—glaucoma	4.97e-05	0.000413	CcSEcCtD
Zoledronate—Dizziness—Travoprost—glaucoma	4.96e-05	0.000413	CcSEcCtD
Zoledronate—CA12—connective tissue—glaucoma	4.95e-05	0.1	CbGeAlD
Zoledronate—Malnutrition—Timolol—glaucoma	4.95e-05	0.000412	CcSEcCtD
Zoledronate—Erythema—Timolol—glaucoma	4.95e-05	0.000412	CcSEcCtD
Zoledronate—Oedema—Betaxolol—glaucoma	4.95e-05	0.000412	CcSEcCtD
Zoledronate—Headache—Brimonidine—glaucoma	4.94e-05	0.000411	CcSEcCtD
Zoledronate—Decreased appetite—Clonidine—glaucoma	4.94e-05	0.000411	CcSEcCtD
Zoledronate—GGPS1—Metabolism—CAV1—glaucoma	4.92e-05	0.000891	CbGpPWpGaD
Zoledronate—Infection—Betaxolol—glaucoma	4.91e-05	0.000409	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Clonidine—glaucoma	4.9e-05	0.000408	CcSEcCtD
Zoledronate—Fatigue—Clonidine—glaucoma	4.9e-05	0.000408	CcSEcCtD
Zoledronate—FDPS—connective tissue—glaucoma	4.9e-05	0.0991	CbGeAlD
Zoledronate—Dizziness—Brinzolamide—glaucoma	4.89e-05	0.000407	CcSEcCtD
Zoledronate—Nausea—Acetazolamide—glaucoma	4.88e-05	0.000406	CcSEcCtD
Zoledronate—Diarrhoea—Pilocarpine—glaucoma	4.87e-05	0.000405	CcSEcCtD
Zoledronate—Shock—Betaxolol—glaucoma	4.87e-05	0.000405	CcSEcCtD
Zoledronate—Pain—Clonidine—glaucoma	4.86e-05	0.000404	CcSEcCtD
Zoledronate—Constipation—Clonidine—glaucoma	4.86e-05	0.000404	CcSEcCtD
Zoledronate—Nervous system disorder—Betaxolol—glaucoma	4.85e-05	0.000404	CcSEcCtD
Zoledronate—Dysgeusia—Timolol—glaucoma	4.85e-05	0.000404	CcSEcCtD
Zoledronate—ABCC1—Transmembrane transport of small molecules—SLC6A13—glaucoma	4.84e-05	0.000876	CbGpPWpGaD
Zoledronate—Thrombocytopenia—Betaxolol—glaucoma	4.84e-05	0.000403	CcSEcCtD
Zoledronate—Tachycardia—Betaxolol—glaucoma	4.83e-05	0.000402	CcSEcCtD
Zoledronate—Skin disorder—Betaxolol—glaucoma	4.8e-05	0.0004	CcSEcCtD
Zoledronate—Vomiting—Dorzolamide—glaucoma	4.79e-05	0.000398	CcSEcCtD
Zoledronate—Hyperhidrosis—Betaxolol—glaucoma	4.78e-05	0.000398	CcSEcCtD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—APOE—glaucoma	4.76e-05	0.000861	CbGpPWpGaD
Zoledronate—Rash—Dorzolamide—glaucoma	4.75e-05	0.000395	CcSEcCtD
Zoledronate—Dermatitis—Dorzolamide—glaucoma	4.74e-05	0.000395	CcSEcCtD
Zoledronate—Rash—Travoprost—glaucoma	4.73e-05	0.000393	CcSEcCtD
Zoledronate—Dermatitis—Travoprost—glaucoma	4.72e-05	0.000393	CcSEcCtD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—CAV1—glaucoma	4.72e-05	0.000854	CbGpPWpGaD
Zoledronate—Headache—Dorzolamide—glaucoma	4.72e-05	0.000393	CcSEcCtD
Zoledronate—Anorexia—Betaxolol—glaucoma	4.71e-05	0.000392	CcSEcCtD
Zoledronate—Vomiting—Brinzolamide—glaucoma	4.71e-05	0.000392	CcSEcCtD
Zoledronate—Dizziness—Pilocarpine—glaucoma	4.7e-05	0.000392	CcSEcCtD
Zoledronate—Headache—Travoprost—glaucoma	4.7e-05	0.000391	CcSEcCtD
Zoledronate—Nausea—Brimonidine—glaucoma	4.68e-05	0.00039	CcSEcCtD
Zoledronate—Feeling abnormal—Clonidine—glaucoma	4.68e-05	0.00039	CcSEcCtD
Zoledronate—Rash—Brinzolamide—glaucoma	4.67e-05	0.000388	CcSEcCtD
Zoledronate—Vision blurred—Timolol—glaucoma	4.67e-05	0.000388	CcSEcCtD
Zoledronate—Dermatitis—Brinzolamide—glaucoma	4.66e-05	0.000388	CcSEcCtD
Zoledronate—Gastrointestinal pain—Clonidine—glaucoma	4.64e-05	0.000387	CcSEcCtD
Zoledronate—Headache—Brinzolamide—glaucoma	4.64e-05	0.000386	CcSEcCtD
Zoledronate—CA14—Metabolism—GSTT1—glaucoma	4.63e-05	0.000838	CbGpPWpGaD
Zoledronate—Hypotension—Betaxolol—glaucoma	4.62e-05	0.000385	CcSEcCtD
Zoledronate—Angioedema—Timolol—glaucoma	4.52e-05	0.000377	CcSEcCtD
Zoledronate—Vomiting—Pilocarpine—glaucoma	4.52e-05	0.000376	CcSEcCtD
Zoledronate—Urticaria—Clonidine—glaucoma	4.51e-05	0.000376	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Betaxolol—glaucoma	4.51e-05	0.000375	CcSEcCtD
Zoledronate—Abdominal pain—Clonidine—glaucoma	4.49e-05	0.000374	CcSEcCtD
Zoledronate—Body temperature increased—Clonidine—glaucoma	4.49e-05	0.000374	CcSEcCtD
Zoledronate—Rash—Pilocarpine—glaucoma	4.48e-05	0.000373	CcSEcCtD
Zoledronate—Dermatitis—Pilocarpine—glaucoma	4.48e-05	0.000373	CcSEcCtD
Zoledronate—Insomnia—Betaxolol—glaucoma	4.47e-05	0.000372	CcSEcCtD
Zoledronate—Nausea—Dorzolamide—glaucoma	4.47e-05	0.000372	CcSEcCtD
Zoledronate—Headache—Pilocarpine—glaucoma	4.46e-05	0.000371	CcSEcCtD
Zoledronate—Nausea—Travoprost—glaucoma	4.45e-05	0.000371	CcSEcCtD
Zoledronate—Vertigo—Timolol—glaucoma	4.45e-05	0.00037	CcSEcCtD
Zoledronate—Paraesthesia—Betaxolol—glaucoma	4.44e-05	0.00037	CcSEcCtD
Zoledronate—Syncope—Timolol—glaucoma	4.44e-05	0.00037	CcSEcCtD
Zoledronate—Dyspnoea—Betaxolol—glaucoma	4.41e-05	0.000367	CcSEcCtD
Zoledronate—Nausea—Brinzolamide—glaucoma	4.4e-05	0.000366	CcSEcCtD
Zoledronate—Palpitations—Timolol—glaucoma	4.37e-05	0.000364	CcSEcCtD
Zoledronate—Dyspepsia—Betaxolol—glaucoma	4.35e-05	0.000362	CcSEcCtD
Zoledronate—Loss of consciousness—Timolol—glaucoma	4.35e-05	0.000362	CcSEcCtD
Zoledronate—Cough—Timolol—glaucoma	4.32e-05	0.00036	CcSEcCtD
Zoledronate—Decreased appetite—Betaxolol—glaucoma	4.3e-05	0.000358	CcSEcCtD
Zoledronate—Hypertension—Timolol—glaucoma	4.27e-05	0.000356	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Betaxolol—glaucoma	4.27e-05	0.000355	CcSEcCtD
Zoledronate—Fatigue—Betaxolol—glaucoma	4.26e-05	0.000355	CcSEcCtD
Zoledronate—Pain—Betaxolol—glaucoma	4.23e-05	0.000352	CcSEcCtD
Zoledronate—Constipation—Betaxolol—glaucoma	4.23e-05	0.000352	CcSEcCtD
Zoledronate—Nausea—Pilocarpine—glaucoma	4.23e-05	0.000352	CcSEcCtD
Zoledronate—Arthralgia—Timolol—glaucoma	4.21e-05	0.000351	CcSEcCtD
Zoledronate—Myalgia—Timolol—glaucoma	4.21e-05	0.000351	CcSEcCtD
Zoledronate—Chest pain—Timolol—glaucoma	4.21e-05	0.000351	CcSEcCtD
Zoledronate—Anxiety—Timolol—glaucoma	4.2e-05	0.00035	CcSEcCtD
Zoledronate—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	4.19e-05	0.000348	CcSEcCtD
Zoledronate—Hypersensitivity—Clonidine—glaucoma	4.19e-05	0.000348	CcSEcCtD
Zoledronate—Discomfort—Timolol—glaucoma	4.16e-05	0.000347	CcSEcCtD
Zoledronate—Dry mouth—Timolol—glaucoma	4.12e-05	0.000343	CcSEcCtD
Zoledronate—Asthenia—Clonidine—glaucoma	4.08e-05	0.000339	CcSEcCtD
Zoledronate—Feeling abnormal—Betaxolol—glaucoma	4.08e-05	0.000339	CcSEcCtD
Zoledronate—Confusional state—Timolol—glaucoma	4.07e-05	0.000339	CcSEcCtD
Zoledronate—FDPS—Metabolism—GSTT1—glaucoma	4.05e-05	0.000732	CbGpPWpGaD
Zoledronate—Anaphylactic shock—Timolol—glaucoma	4.04e-05	0.000336	CcSEcCtD
Zoledronate—Oedema—Timolol—glaucoma	4.04e-05	0.000336	CcSEcCtD
Zoledronate—Pruritus—Clonidine—glaucoma	4.02e-05	0.000335	CcSEcCtD
Zoledronate—Infection—Timolol—glaucoma	4.01e-05	0.000334	CcSEcCtD
Zoledronate—Shock—Timolol—glaucoma	3.97e-05	0.000331	CcSEcCtD
Zoledronate—Nervous system disorder—Timolol—glaucoma	3.96e-05	0.00033	CcSEcCtD
Zoledronate—Urticaria—Betaxolol—glaucoma	3.93e-05	0.000327	CcSEcCtD
Zoledronate—Skin disorder—Timolol—glaucoma	3.92e-05	0.000327	CcSEcCtD
Zoledronate—Body temperature increased—Betaxolol—glaucoma	3.91e-05	0.000325	CcSEcCtD
Zoledronate—Hyperhidrosis—Timolol—glaucoma	3.91e-05	0.000325	CcSEcCtD
Zoledronate—CA12—Metabolism—GSTT1—glaucoma	3.9e-05	0.000706	CbGpPWpGaD
Zoledronate—Diarrhoea—Clonidine—glaucoma	3.89e-05	0.000324	CcSEcCtD
Zoledronate—Anorexia—Timolol—glaucoma	3.85e-05	0.000321	CcSEcCtD
Zoledronate—CA2—Metabolism—TXN—glaucoma	3.85e-05	0.000696	CbGpPWpGaD
Zoledronate—Hypotension—Timolol—glaucoma	3.78e-05	0.000314	CcSEcCtD
Zoledronate—Dizziness—Clonidine—glaucoma	3.76e-05	0.000313	CcSEcCtD
Zoledronate—GGPS1—Metabolism—NOS3—glaucoma	3.72e-05	0.000673	CbGpPWpGaD
Zoledronate—CA14—Metabolism—ABCA1—glaucoma	3.69e-05	0.000667	CbGpPWpGaD
Zoledronate—CA14—Metabolism—CYP1B1—glaucoma	3.69e-05	0.000667	CbGpPWpGaD
Zoledronate—Musculoskeletal discomfort—Timolol—glaucoma	3.68e-05	0.000306	CcSEcCtD
Zoledronate—Insomnia—Timolol—glaucoma	3.65e-05	0.000304	CcSEcCtD
Zoledronate—Hypersensitivity—Betaxolol—glaucoma	3.64e-05	0.000303	CcSEcCtD
Zoledronate—Paraesthesia—Timolol—glaucoma	3.63e-05	0.000302	CcSEcCtD
Zoledronate—Vomiting—Clonidine—glaucoma	3.61e-05	0.000301	CcSEcCtD
Zoledronate—Dyspnoea—Timolol—glaucoma	3.6e-05	0.0003	CcSEcCtD
Zoledronate—Somnolence—Timolol—glaucoma	3.59e-05	0.000299	CcSEcCtD
Zoledronate—Rash—Clonidine—glaucoma	3.58e-05	0.000298	CcSEcCtD
Zoledronate—Dermatitis—Clonidine—glaucoma	3.58e-05	0.000298	CcSEcCtD
Zoledronate—Headache—Clonidine—glaucoma	3.56e-05	0.000296	CcSEcCtD
Zoledronate—Dyspepsia—Timolol—glaucoma	3.56e-05	0.000296	CcSEcCtD
Zoledronate—Asthenia—Betaxolol—glaucoma	3.55e-05	0.000295	CcSEcCtD
Zoledronate—ABCC1—Transmembrane transport of small molecules—SLC6A1—glaucoma	3.55e-05	0.000641	CbGpPWpGaD
Zoledronate—Decreased appetite—Timolol—glaucoma	3.51e-05	0.000292	CcSEcCtD
Zoledronate—Pruritus—Betaxolol—glaucoma	3.5e-05	0.000291	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Timolol—glaucoma	3.49e-05	0.00029	CcSEcCtD
Zoledronate—Fatigue—Timolol—glaucoma	3.48e-05	0.00029	CcSEcCtD
Zoledronate—Pain—Timolol—glaucoma	3.45e-05	0.000288	CcSEcCtD
Zoledronate—ABCC1—Disease—FGFR1OP—glaucoma	3.45e-05	0.000624	CbGpPWpGaD
Zoledronate—ABCC1—Disease—HEYL—glaucoma	3.45e-05	0.000624	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—PTGS2—glaucoma	3.41e-05	0.000616	CbGpPWpGaD
Zoledronate—Diarrhoea—Betaxolol—glaucoma	3.38e-05	0.000282	CcSEcCtD
Zoledronate—Nausea—Clonidine—glaucoma	3.37e-05	0.000281	CcSEcCtD
Zoledronate—Feeling abnormal—Timolol—glaucoma	3.33e-05	0.000277	CcSEcCtD
Zoledronate—Gastrointestinal pain—Timolol—glaucoma	3.3e-05	0.000275	CcSEcCtD
Zoledronate—Dizziness—Betaxolol—glaucoma	3.27e-05	0.000272	CcSEcCtD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	3.26e-05	0.00059	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—CYP1B1—glaucoma	3.23e-05	0.000583	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—ABCA1—glaucoma	3.23e-05	0.000583	CbGpPWpGaD
Zoledronate—Urticaria—Timolol—glaucoma	3.21e-05	0.000267	CcSEcCtD
Zoledronate—Abdominal pain—Timolol—glaucoma	3.19e-05	0.000266	CcSEcCtD
Zoledronate—Body temperature increased—Timolol—glaucoma	3.19e-05	0.000266	CcSEcCtD
Zoledronate—Vomiting—Betaxolol—glaucoma	3.14e-05	0.000262	CcSEcCtD
Zoledronate—Rash—Betaxolol—glaucoma	3.12e-05	0.00026	CcSEcCtD
Zoledronate—Dermatitis—Betaxolol—glaucoma	3.12e-05	0.000259	CcSEcCtD
Zoledronate—CA12—Metabolism—CYP1B1—glaucoma	3.11e-05	0.000562	CbGpPWpGaD
Zoledronate—CA12—Metabolism—ABCA1—glaucoma	3.11e-05	0.000562	CbGpPWpGaD
Zoledronate—Headache—Betaxolol—glaucoma	3.1e-05	0.000258	CcSEcCtD
Zoledronate—CA2—Metabolism—GSTT1—glaucoma	2.98e-05	0.00054	CbGpPWpGaD
Zoledronate—Hypersensitivity—Timolol—glaucoma	2.98e-05	0.000248	CcSEcCtD
Zoledronate—CA14—Metabolism—GSTM1—glaucoma	2.95e-05	0.000533	CbGpPWpGaD
Zoledronate—Nausea—Betaxolol—glaucoma	2.94e-05	0.000245	CcSEcCtD
Zoledronate—Asthenia—Timolol—glaucoma	2.9e-05	0.000241	CcSEcCtD
Zoledronate—ABCC1—Metabolism—CA1—glaucoma	2.89e-05	0.000523	CbGpPWpGaD
Zoledronate—Pruritus—Timolol—glaucoma	2.86e-05	0.000238	CcSEcCtD
Zoledronate—ABCC1—Metabolism—CTSA—glaucoma	2.8e-05	0.000506	CbGpPWpGaD
Zoledronate—Diarrhoea—Timolol—glaucoma	2.76e-05	0.00023	CcSEcCtD
Zoledronate—Dizziness—Timolol—glaucoma	2.67e-05	0.000222	CcSEcCtD
Zoledronate—ABCC1—Metabolism—CA2—glaucoma	2.64e-05	0.000478	CbGpPWpGaD
Zoledronate—CA2—eye—glaucoma	2.64e-05	0.0534	CbGeAlD
Zoledronate—CA2—retina—glaucoma	2.61e-05	0.0529	CbGeAlD
Zoledronate—CA14—Metabolism—MTHFR—glaucoma	2.61e-05	0.000471	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	2.58e-05	0.000467	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	2.58e-05	0.000467	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—GSTM1—glaucoma	2.58e-05	0.000466	CbGpPWpGaD
Zoledronate—Vomiting—Timolol—glaucoma	2.57e-05	0.000214	CcSEcCtD
Zoledronate—Rash—Timolol—glaucoma	2.55e-05	0.000212	CcSEcCtD
Zoledronate—Dermatitis—Timolol—glaucoma	2.54e-05	0.000212	CcSEcCtD
Zoledronate—CA2—connective tissue—glaucoma	2.54e-05	0.0515	CbGeAlD
Zoledronate—Headache—Timolol—glaucoma	2.53e-05	0.000211	CcSEcCtD
Zoledronate—CA12—Metabolism—GSTM1—glaucoma	2.49e-05	0.00045	CbGpPWpGaD
Zoledronate—CA14—Metabolism—APOE—glaucoma	2.43e-05	0.000439	CbGpPWpGaD
Zoledronate—CA14—Metabolism—CAV1—glaucoma	2.4e-05	0.000435	CbGpPWpGaD
Zoledronate—Nausea—Timolol—glaucoma	2.4e-05	0.0002	CcSEcCtD
Zoledronate—CA2—Metabolism—CYP1B1—glaucoma	2.38e-05	0.00043	CbGpPWpGaD
Zoledronate—CA2—Metabolism—ABCA1—glaucoma	2.38e-05	0.00043	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—MTHFR—glaucoma	2.28e-05	0.000412	CbGpPWpGaD
Zoledronate—CA12—Metabolism—MTHFR—glaucoma	2.2e-05	0.000397	CbGpPWpGaD
Zoledronate—ABCC1—Disease—HDAC9—glaucoma	2.15e-05	0.00039	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—APOE—glaucoma	2.12e-05	0.000384	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—CAV1—glaucoma	2.1e-05	0.00038	CbGpPWpGaD
Zoledronate—CA12—Metabolism—APOE—glaucoma	2.05e-05	0.00037	CbGpPWpGaD
Zoledronate—CA12—Metabolism—CAV1—glaucoma	2.03e-05	0.000367	CbGpPWpGaD
Zoledronate—CA2—Metabolism—GSTM1—glaucoma	1.9e-05	0.000344	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—TXN—glaucoma	1.86e-05	0.000337	CbGpPWpGaD
Zoledronate—CA14—Metabolism—NOS3—glaucoma	1.82e-05	0.000329	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.7e-05	0.000307	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.68e-05	0.000305	CbGpPWpGaD
Zoledronate—CA2—Metabolism—MTHFR—glaucoma	1.68e-05	0.000304	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PTGS2—glaucoma	1.66e-05	0.000301	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—NOS3—glaucoma	1.59e-05	0.000287	CbGpPWpGaD
Zoledronate—CA2—Metabolism—APOE—glaucoma	1.56e-05	0.000283	CbGpPWpGaD
Zoledronate—CA2—Metabolism—CAV1—glaucoma	1.55e-05	0.00028	CbGpPWpGaD
Zoledronate—CA12—Metabolism—NOS3—glaucoma	1.53e-05	0.000277	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PTGS2—glaucoma	1.45e-05	0.000263	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GSTT1—glaucoma	1.44e-05	0.000261	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PTGS2—glaucoma	1.4e-05	0.000253	CbGpPWpGaD
Zoledronate—CA2—Metabolism—NOS3—glaucoma	1.17e-05	0.000212	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.16e-05	0.000211	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CDKN2B—glaucoma	1.16e-05	0.00021	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CYP1B1—glaucoma	1.15e-05	0.000208	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ABCA1—glaucoma	1.15e-05	0.000208	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PTGS2—glaucoma	1.07e-05	0.000194	CbGpPWpGaD
Zoledronate—ABCC1—Disease—MTHFR—glaucoma	9.71e-06	0.000176	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GSTM1—glaucoma	9.2e-06	0.000166	CbGpPWpGaD
Zoledronate—ABCC1—Disease—APOE—glaucoma	9.04e-06	0.000163	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CAV1—glaucoma	8.96e-06	0.000162	CbGpPWpGaD
Zoledronate—ABCC1—Disease—BAD—glaucoma	8.42e-06	0.000152	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—MTHFR—glaucoma	8.13e-06	0.000147	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—APOE—glaucoma	7.57e-06	0.000137	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CAV1—glaucoma	7.5e-06	0.000136	CbGpPWpGaD
Zoledronate—ABCC1—Disease—NOS3—glaucoma	6.77e-06	0.000122	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PTGS2—glaucoma	6.19e-06	0.000112	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CDKN1B—glaucoma	5.87e-06	0.000106	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—NOS3—glaucoma	5.67e-06	0.000103	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PTGS2—glaucoma	5.19e-06	9.38e-05	CbGpPWpGaD
